BioSpace News Archive

Business

GRAIL Appoints Gautam Kollu as Chief Commercial Officer

Mr. Kollu joins GRAIL from Illumina, Inc. where he most recently served as Vice President, Global Market Development and led the teams that drove the commercial adoption of genomics in multiple applications including noninvasive prenatal testing and liquid biopsy.

December 16, 2019
·
2 min read
Business

Blueberries Medical Appoints Co-Founder Camilo Villalba as CEO, Exports Expected to Commence in First Half of 2020

Dr. Patricio Stocker will continue to support Blueberries as a Senior Strategic Consultant focused on expanding the Company’s international cannabis sales and other strategic initiatives.

December 16, 2019
·
7 min read
Biotech Bay

Alector Showcases Progress in Immuno-Neurology Clinical Programs and Research Portfolio at R&D Day

Reported results from analysis of the Phase 1b study of AL001 in patients with symptomatic FTD-GRN showing a statistically significant normalization in a number of disease-associated proteins and an initial trend of a decrease compared to baseline levels in plasma Neurofilament

December 16, 2019
·
7 min read
Policy

Eiger Initiates Rolling Submission of New Drug Application (NDA) with FDA for Lonafarnib for Treatment of Progeria and Progeroid Laminopathies

Eiger BioPharmaceuticals, Inc. announced that it has initiated submission of a New Drug Application for Lonafarnib for the treatment of Hutchinson-Gilford Progeria Syndrome and Progeroid Laminopathies to the U.S. Food & Drug Administration under the Rolling Review Process.

December 16, 2019
·
7 min read
FDA

XTANDI® (enzalutamide) Approved by U.S. FDA for the Treatment of Metastatic Castration-Sensitive Prostate Cancer

XTANDI is Now FDA-Approved for the Treatment of Metastatic Castration-Sensitive Prostate Cancer in Addition to Non-Metastatic and Metastatic Castration-Resistant Prostate Cancer

December 16, 2019
·
16 min read